Palabras clave
Enfermedad de Chagas
Atención Primaria de Salud
Cómo citar
Copyright © | Todos los derechos reservados.
La revista posee los derechos de autor exclusivos para la publicación de este artículo en los términos de la ley brasileña 9610/98.
Reproducción parcial
El uso de partes de los textos, figuras y cuestionario del artículo es libre, siendo obligatoria la citación de los autores y revista.
Reproducción total
Está expresamente prohibido y debe ser autorizado por la revista.
Resumen
Objetivo: DISCUTIR los obstáculos que atraviesan la Atención Primaria de Salud para el manejo y control de la enfermedad de Chagas en Brasil. Revisión bibliográfica: A pesar de los avances e impactos de las actividades de prevención y control de la enfermedad de Chagas adoptadas en el ámbito de las políticas en Brasil, aún persisten inmensas brechas que refuerzan la negligencia de la enfermedad. Consideraciones finales: Las barreras mencionadas hasta ahora demuestran, en parte, una falta de interés por parte de las agendas políticas en asumir y/o implementar acciones más efectivas relacionadas con la enfermedad de Chagas, que a su vez, ha sido superada por programas más visibles. y enfermedades, quizás debido a la larga evolución clínica de la enfermedad y a las características de poblaciones comúnmente afectadas que tienen baja expresión social. Los pacientes afectados carecen de representación y mayor acceso a las redes de atención permanente y calificada del Sistema Único de Salud en todos los niveles de atención. Sólo cuando se articulen de manera efectiva importantes reformas políticas, sociales, ambientales y educativas, la enfermedad de Chagas se caracterizará como una enfermedad controlada en el país.
Referencias
ANDRADE JP, et al. Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arquivos Brasileiros de Cardiologia, 2011; 96(6): 434–442.
ARAUJO-JORGE TC, et al. “Chagas Express XXI": A new ArtScience social technology for health and science education-A case study in Brazilian endemic areas of Chagas disease with an active search of chronic cases. PLoS Neglected Tropical Diseases, 2021; 15(7): 1-33.
BARROS F, et al. Agreement between upper endoscopy and esophagography in the diagnosis of megaesophagus in Chagas disease. Revista da Sociedade Brasileira de Medicina Tropical, 2019; 52:1-5.
BRASIL. Decreto nº 49.974-A. 10961. Diário Oficial da União. Disponível em: https://www.planalto.gov.br/ccivil_03/atos/decretos/1961/d49974a.html. Acesso em: 03. Jul. 2024.
BRASIL. Ministério da Saúde. Portaria nº 202, de 17 de fevereiro de 2009a. Disponível em:
https://bvsms.saude.gov.br/bvs/saudelegis/funasa/2009/prt0202_17_02_2009.html Acesso em: 03. Jul. 2024.
BRASIL. Secretaria de Atenção à Saúde. Vigilância em Saúde: Zoonoses. Cadernos de Atenção Básica. 2009b. Disponível em: http://189.28.128.100/dab/docs/publicacoes/cadernos_ab/abcad22.pdf Acesso em: 03. Jul. 2024.
BRASIL. Ministério da Saúde. Portaria nº 104, de 25 de janeiro de 2010. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt0104_25_01_2011.html Acesso em: 03. Jul. 2024.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de Vigilância em Saúde. Brasília: Ministério da Saúde. 2014. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/guia_vigilancia_saude_5ed_rev_atual.pdf Acesso em: 03. Jul. 2024.
BRASIL. Ministério da Saúde. Recomendações sobre o diagnóstico parasitológico, sorológico e molecular para confirmação da doença de chagas aguda e crônica. Revista de Patologia Tropical, 2013; 42(4).
BRASIL. Ministério da Saúde. Protocolo Clínico e Diretrizes Terapêuticas da doença de Chagas. Brasília: Ministério da Saúde. 2018. Disponível em: https://www.gov.br/saude/pt-br/centrais-de conteudo/publicacoes/svsa/doenca-de-chagas/protocolo-clinico-e-diretrizes-terapeuticas-para-doenca-de-chagas-_-relatorio-de-recomendacao.pdf. Acesso em: 03. Jul. 2024.
Brasil. Ministério da Saúde. Portaria nº 264, de 17 de fevereiro de 2020. Disponível em: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2020/prt0264_19_02_2020.htm Acesso em: 03. Jul. 2024.
BRASIL PE, et al. ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis. BMC Infectious Diseases, 2010; 10 (337).
CARDOSO LP, et al. Spatial distribution of Chagas disease and its correlation with health services. Revista da Escola de Enfermagem da USP, 2020; 54: 1-8.
COURA JR. The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions--a comprehensive review. Memórias do Instituto Oswaldo Cruz, 2015; 110(3): 277–282.
ARIAS AR, et al. Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission. Memórias do Instituto Oswaldo Cruz, 2022; 117: 1-15.
DIAS JC. Globalization, inequity and Chagas disease. Cad. Saude Publica, 2007; 23 (Suppl 1): 13–22.
DIAS JC, et al. 2 nd Brazilian Consensus on Chagas Disease, 2015. Revista da Sociedade Brasileira de Medicina Tropical, 2016; 49 (Suppl 1): 3–60.
GONZÁLEZ S, et al. Short-course combination treatment for experimental chronic Chagas disease. Sci. Transl. Med, 2023; 15(726).
HERNÁNDEZ C, et al. Molecular Diagnosis of Chagas Disease in Colombia: Parasitic Loads and Discrete Typing Units in Patients from Acute and Chronic Phases. PLOS Neglected Tropical Diseases, 2016; 10(9).
SANTOS JP, et al. Assessing the entomo-epidemiological situation of Chagas disease in rural communities in the state of Piauí, Brazilian semi-arid region. Transactions of The Royal Society of Tropical Medicine and Hygiene, 2020; 114(11): 820–829.
HOCHBERG NS, MONTGOMERY SP. Chagas Disease. Annals of Internal Medicine, 2023; 176(2): 13-32.
JANSEN AM, XAVIER SCDC, ROQUE ALR. Trypanosoma cruzi transmission in the wild and its most important reservoir hosts in Brazil. Parasit. Vectors, 2018; 11(1): 502.
KOH CC, et al. Cytokine Networks as Targets for Preventing and Controlling Chagas Heart Disease. Pathogens, 2023; 12(2): 171.
KRATZ JM. Drug discovery for chagas disease: A viewpoint. Acta Tropica, 2019; 198: 105-107.
KRATZ JM, et al. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease. Expert Review of Clinical Pharmacology, 2018; 11(10): 943–957.
MASSAD E. The elimination of Chagas' disease from The Brazilian Journal of Infectious Diseases, 2008; 136(9): 1153–1164.
MEDEIROS CA, et al. Mapping the morbidity and mortality of Chagas disease in na endemic area in Brazil. Revista do Instituto de Medicina Tropical, 2022; 64: 1-12.
MENDES FSNS, et al. Critical analysis of Chagas disease treatment in different countries. Memórias do Instituto Oswaldo Cruz, 2022; 8:117.
PÉREZ-MOLINA JÁ, et al. Trypanocidal treatment of Chagas disease. Enferm. Infecc. Microbiol. Clin. Enfermedades Infecciosas y Microbiología Clínica (English ed), 2021; 39(9):458-470.
PINHEIROS E, et al. Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America. Revista da Sociedade Brasileira de Medicina Tropical, 2017; 50(3): 296–300.
RAMOS-JUNIOR NA, SOUSA AS. The continuous challenge of Chagas disease treatment: bridging evidence-based guidelines, access to healthcare, and human rights. Revista da Sociedade Brasileira de Medicina Tropical, 2017; 50(6): 745–747.
ROJAS-DE-ARIAS A. Chagas disease prevention through improved housing using na ecosystem approach to health. Cadernos de Saúde Pública, 2001; 17 (Suppl): 89–97.
ROLON M, et al. Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease. Pharmaceutics, 2022; 14(9): 1822.
SÁNCHEZ-CAMARGO CL, et al. Comparative evaluation of 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in sérum banks in areas of endemicity and nonendemicity. Journal of Clinical Microbiology, 2014; 52(7): 2506–2512.
SANTOS JPD, et al. Spatial distribution of synanthropic triatomines in Piaui State, Northeastern Brazil. Revista do Instituto de Medicina Tropical, 2020; 62: 1-13.
SANTOS SMD, et al. Entomological survey in the state of Piauí, Northeastern Brazil, reveals intradomiciliary colonization of Triatoma brasiliensis macromelasoma. Revista do Instituto de Medicina Tropical, 2017; 59:1-15.
SILVEIRA AC, DIAS JC. The control of vectorial transmission. Revista da Sociedade Brasileira De Medicina Tropical, 2011; 44(Suppl 2): 52–63.
SILVEIRA AC, PIMENTA, FJR. Institutional insertion of Chagas' disease control. Revista da Sociedade Brasileira De Medicina Tropical, 2011; 44(Suppl 2): 19–24.
SOARES CAJAIBA-SOARES A, et al. Healthcare Workers' Knowledge about Chagas Disease: A Systematic Review. The American Journal of Tropical Medicine and Hygiene, 2021; 104(5): 1631–1638.
SOUZA RCM, et al. Chagas disease in the context of the 2030 agenda: global warming and vectors. Memórias do Instituto Oswaldo Cruz, 2022; 117:1-14.
TORRES RM, et al. Prognosis of chronic Chagas heart disease and other pending clinical challenges. Memórias do Instituto Oswaldo Cruz, 2022; 117: 1-17.
VILLELA MM, et al. Evaluation of the Chagas Disease Control Program and presence of Panstrongylus megistus in central-western Minas Gerais State, Brazil. Cadernos de Saúde Pública, 2009; 25(4): 907–917.
WENDEL S. Transfusion transmitted Chagas disease: is it really under control?. Acta Tropica, 2010; 115(1-2):28–34.